Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait

被引：0
|
作者：
Jasem AL-Hashel
Samar F. Ahmed
Raed Behbehani
Raed Alroughani
机构：
[1] Ibn Sina Hospital,Department of Neurology
[2] Kuwait University,Faculty of Medicine
[3] Minia University,Department of Neurology and Psychiatry
[4] Al-Bahar Eye Center,Department of Ophthalmology
[5] Dasman Diabetes Institute,Neurology Clinic
[6] Amiri Hospital,Division of Neurology, Department of Medicine
来源：
CNS Drugs | 2014年 / 28卷
关键词：
Multiple Sclerosis; Expand Disability Status Scale; Natalizumab; Glatiramer Acetate; Fingolimod;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 824
页数：7
相关论文
共 50 条
  • [21] Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
    Druart, Charlotte
    El Sankari, Souraya
    van Pesch, Vincent
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 1 - 10
  • [22] Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients
    Miryam Cannizzaro
    Laura Ferré
    Ferdinando Clarelli
    Antonino Giordano
    Francesca Sangalli
    Bruno Colombo
    Giancarlo Comi
    Lucia Moiola
    Vittorio Martinelli
    Massimo Filippi
    Federica Esposito
    Journal of Neurology, 2022, 269 : 5596 - 5605
  • [23] Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients
    Esposito, F.
    Ferre, L.
    Clarelli, F.
    Rocca, M. A.
    Sferruzza, G.
    Storelli, L.
    Radaelli, M.
    Sangalli, F.
    Moiola, L.
    Colombo, B.
    Boneschi, F. Martinelli
    Comi, G.
    Filippi, M.
    Martinelli, V.
    JOURNAL OF NEUROLOGY, 2018, 265 (04) : 896 - 905
  • [24] Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
    Yavari, Fatemeh
    Oliazadeh, Pardis
    Radfar, Meisam
    Foroughipour, Mohsen
    Nikkhah, Karim
    Bakavoli, Alireza Heidari
    Saeidi, Morteza
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 233 - 242
  • [25] Real-World Safety and Patient Profile of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Miguez, Jimena
    Cristiano, Edgardo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) : 251 - 254
  • [26] Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis
    Derfuss, T.
    Bergvall, N. K.
    Sfikas, N.
    Tomic, D. L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1687 - 1691
  • [27] Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study
    Tourbah, Ayman
    Papeix, Caroline
    Tourniaire, Patricia
    Rerat, Karin
    Meite, Mohamed
    Durand, Barbara
    Lamy, Fabienne
    Chouette, Isabelle
    Mekies, Claude
    Aboab, Jennyfer
    Al Khedr, Abdullatif
    Carpentier, Amer Al Najjar
    Androdias, Geraldine
    Benrabah, Rabah
    Biotti, Damien
    Bohotin, Valentin
    Bonnan, Mickael
    Bonnet, Cecilia
    Boulesteix, Jean Marc
    Brassat, David
    Busson, Philippe
    Camu, William
    Castelnovo, Giovanni
    Chapuis, Stephane
    Clavelou, Pierre
    Convers, Philippe
    Coustans, Marc
    Creange, Alain
    Delassaux, Sebastien
    Diot, Eric
    Djerdi, Madjid
    Drouet, Thomas
    Delalande, Sophie Dufour
    Pottier, Corinne Dupel
    Ferriby, Didier
    Gaida, Philippe
    Gal, Guillaume
    Giraud, Pierric
    Guilloton, Laurent
    Hascar, Tijani
    Heinzlef, Olivier
    Rouaud, Violaine Jaffrenou
    Jager, Alain
    Kubler, Christophe
    Le Coz, Patrick
    Frenay, Christine Lebrun
    Maillart, Elisabeth
    Vioud, Paris Marcel Maillet
    Malkoun, Imad
    Manchon, Eric
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [28] A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study
    Gauer, L.
    Bigaut, K.
    Berger, E.
    Debouverie, M.
    Moreau, T.
    de Seze, J.
    REVUE NEUROLOGIQUE, 2023, 179 (06) : 576 - 584
  • [29] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Ozakbas, Serkan
    Terzi, Murat
    Karabudak, Rana
    Sevim, Serhan
    Turkoglu, Recai
    Soysal, Aysun
    Balci, Belgin Petek
    Efendi, Husnu
    Turan, Omer Faruk
    Yuceyar, Nur
    Yetkin, Mehmet Fatih
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Guler, Sibel
    Agan, Kadriye
    Kiylioglu, Nefati
    Baba, Cavid
    Tuncer, Asli
    Koseoglu, Mesrure
    NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
  • [30] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Yao
    Yin, Hexiang
    Zhang, Dingding
    Xu, Yan
    Peng, Bin
    Cui, Liying
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4808 - 4816
12345